Therapeutic Area | MeSH |
---|---|
urogenital diseases | D000091642 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
prostatic hyperplasia | EFO_0000284 | D011470 | N40 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic hyperplasia | D011470 | EFO_0000284 | N40 | — | — | 1 | 1 | — | 2 |
Hyperplasia | D006965 | EFO_0000536 | — | — | — | 1 | 1 | — | 2 |
Drug common name | Silodosin |
INN | silodosin |
Description | Silodosin is an indolecarboxamide. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F |
PDB | — |
CAS-ID | 160970-54-7 |
RxCUI | — |
ChEMBL ID | CHEMBL24778 |
ChEBI ID | — |
PubChem CID | 5312125 |
DrugBank | DB06207 |
UNII ID | CUZ39LUY82 (ChemIDplus, GSRS) |